Some carcinomas, such as colorectal adenocarcinoma, hepatocellular carcinoma, cholangiocarcinoma, gastric adenocarcinoma, lung adenocarcinoma, and papillary and follicular thyroid carcinoma, have less than 10% of GATA3 expression rates [59]. This evidence concerns the gene GATA3 and lung adenocarcinoma.